Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

This study has been completed.
Agensys, Inc.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: August 20, 2007
Last updated: April 30, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)